Organization · Venture Capital
朗盛投资
朗盛投资 (Lang Sheng Investment) is a Shanghai-based venture capital firm founded in 2010, focusing on investments in the healthcare sector, particularly in biopharmaceuticals and medical devices. The firm manages approximately 1.3 billion yuan and has invested in over 30 companies, nurturing several unicorns.
Overview
What 朗盛投资 does
What 朗盛投资 is
朗盛投资 (Lang Sheng Investment) is a Shanghai-based venture capital firm founded in 2010, focusing on investments in the healthcare sector, particularly in biopharmaceuticals and medical devices. The firm manages approximately 1.3 billion yuan and has invested in over 30 companies, nurturing several unicorns.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find 朗盛投资 elsewhere
Open the official website or a supported primary organization account.
Capability profile
朗盛投资 as a funder
Investment thesis
Back innovative Chinese healthcare and data-driven TMT companies at growth stage (A-B rounds).
Focus narrative
朗盛投资专注于医疗健康领域，投资生物制药、生物技术、医疗设备和医疗服务。该组织在选择、投资和赋能医疗健康项目方面拥有丰富的经验，主要投资于早期公司，包括天使轮和A轮融资，并特别关注中国市场。
Value beyond capital
朗盛投资通过其丰富的行业经验和广泛的网络，为投资组合公司提供战略指导、市场进入支持和资源整合，帮助企业加速成长和创新。
Terms and economics
- Typical check
- $1,000,000–$5,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Angel · Series A · Series B
- Sectors
- Healthcare · Biotech · Medical Devices
- Regions
- Asia · Greater China
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
- Recorded notable exits
- Ankon Technologies and CapitalBio Corporation
Portfolio context
朗盛投资的知名投资组合公司包括： 安翰科技: 开发了全球首个主动控制的胶囊内窥镜机器人。 莱馥生命科技: 专注于干细胞存储和细胞治疗技术。 博奥晶典: 专注于下一代生物检测技术和个性化医学。 艾比玛特: 提供基于单克隆抗体的蛋白质组学研究平台。 国药健康在线: 中国最大的药品分销公司发起的药品电商平台。
Common questions
What to know about 朗盛投资
Upseed classifies 朗盛投资 under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.